NCT05109325 is a NA clinical trial of IntERact in Firearm Violence, sponsored by University of Michigan.

Who is sponsoring NCT05109325?

NCT05109325 is sponsored by University of Michigan.

What drugs are being tested in NCT05109325?

Interventions in NCT05109325: IntERact.

What condition does NCT05109325 study?

NCT05109325 studies Firearm Violence, Firearm Carriage, Injury Prevention.

Is NCT05109325 still recruiting?

NCT05109325 is currently completed. Last updated 30 October 2025.

Last reviewed 2025-10-30 · How we verify

NCT05109325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Project IntERact V2

Completed NA Last updated 30 October 2025

What this trial tests

NA trial testing IntERact in Firearm Violence in 373 participants. Completed in 15 May 2025.

Timeline

24 January 2022

Primary endpoint
15 May 2025

15 May 2025

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	373
Start date	24 January 2022
Primary completion	15 May 2025
Estimated completion	15 May 2025
Sites	3 locations across United States

Drugs / interventions tested

IntERact

Conditions studied

Firearm Violence — all drugs for Firearm Violence →
Firearm Carriage — all drugs for Firearm Carriage →
Injury Prevention — all drugs for Injury Prevention →

Sponsor

University of Michigan

Who can join

Adults 16 to 30, any sex, with Firearm Violence or Firearm Carriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is evaluating the efficacy of a behavioral intervention to reduce risky firearm carriage among a high risk sample of youth reporting recent firearm carriage and ownership of a smartphone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of IntERact

Trials testing the same drug.

NCT03940716 — Project IntERact Study · NA · completed

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05109325 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 30 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05109325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing